Cargando…
MDA5 complements TLR3 in suppression of neuroblastoma
Toll-like receptor3 (TLR3) has been confirmed to be differentially expressed in neuroblastoma (NB), and predicts a favorable prognosis with a high expression in tumor tissues. Treatment with TLR3 agonist - polyinosinic-polycytidylic acid [poly(I:C)] could induce significant but limited apoptosis in...
Autores principales: | Hsu, Wen-Ming, Huang, Chao-Cheng, Lee, Hsin-Yu, Wu, Pei-Yi, Wu, Min-Tsui, Chuang, Hui-Ching, Lin, Li-Ling, Chuang, Jiin-Haur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694805/ https://www.ncbi.nlm.nih.gov/pubmed/26208481 |
Ejemplares similares
-
Innate immune sensor laboratory of genetics and physiology 2 suppresses tumor cell growth and functions as a prognostic marker in neuroblastoma
por: Lin, Li‐Ling, et al.
Publicado: (2018) -
ONC201 Suppresses Neuroblastoma Growth by Interrupting Mitochondrial Function and Reactivating Nuclear ATRX Expression While Decreasing MYCN
por: Wu, Jian-Ching, et al.
Publicado: (2023) -
5-aza-2′-Deoxycytidine Induces a RIG-I-Related Innate Immune Response by Modulating Mitochondria Stress in Neuroblastoma
por: Lin, Hung-Yu, et al.
Publicado: (2020) -
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
por: Chuang, Jiin-Haur, et al.
Publicado: (2011) -
Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice
por: Huang, Chao-Cheng, et al.
Publicado: (2015)